Eurotex Industries & Exports Ltd. - Research Center
521014 EUROTEXIND Group (B) BSE data
Add to watchlist
| Results |
Annual
|
| Statement | |
| More |
Annual results in brief
(Rs crore)
| Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | Mar ' 18 | |
|---|---|---|---|---|---|
| Sales | 2.25 | 23.64 | 42.06 | 196.75 | 252.05 |
| Operating profit | -7.37 | -16.22 | -21.16 | -7.99 | -5.24 |
| Interest | 2.54 | 3.19 | 4.47 | 6.79 | 7.20 |
| Gross profit | -7.37 | -8.39 | -18.09 | -13.38 | -11.30 |
| EPS (Rs) | -13.39 | -13.42 | -21.46 | -19.53 | -16.21 |
Annual
results in details
| Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | Mar ' 18 | |
|---|---|---|---|---|---|
| Other income | 2.55 | 11.02 | 7.54 | 1.40 | 1.14 |
| Stock adjustment | 0.87 | 6.92 | 13.89 | -1.50 | 6.38 |
| Raw material | - | - | 13.97 | 89.93 | 129.69 |
| Power and fuel | - | - | 0.99 | 18.69 | 24.89 |
| Employee expenses | 4.73 | 14.70 | 18.27 | 20.41 | 23.51 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 4.02 | 18.25 | 16.10 | 77.22 | 72.82 |
| Provisions made | - | - | - | - | - |
| Depreciation | 3.30 | 3.66 | 3.71 | 3.91 | 3.98 |
| Taxation | 1.03 | -0.32 | -3.04 | -0.21 | -1.11 |
| Net profit / loss | -11.70 | -11.73 | -18.75 | -17.07 | -14.17 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 8.74 | 8.74 | 8.74 | 8.74 | 8.74 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | -327.37 | -68.61 | -50.31 | -4.06 | -2.08 |
| GPM (%) | -153.40 | -24.20 | -36.47 | -6.75 | -4.46 |
| NPM (%) | -243.72 | -33.84 | -37.81 | -8.62 | -5.60 |
Mutual Fund Selector
Find the fund that is right for you
© 2022 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis